SCOR Ventures, the venture capital arm of the global reinsurer SCOR, focuses its investments on early-stage companies (Seed to Series B) globally, particularly in North America, EMEA, and LATAM. Their strategy centers on three main theses: "Insurers of the Future" (tech-driven underwriting and distribution), "Innovative Technology" (software solutions for SCOR and its clients), and "Healthier Lives" (health and technology intersection). They typically seek over 5% ownership and aim for long-term partnerships rather than quick exits or acquisitions.
40% of their portfolio is in Insurance. Their most common stage is series-b (80% of deals). Average disclosed round size is $44.1M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$23.7B
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 ifeel | Series B | $18.5M | May 2024 |
 Novisto | Series B | $20M | May 2023 |
| FFinanzguru | Series A | $14M | Apr 2023 |
 Marshmallow | Series B | $83M | Sep 2021 |
| Marshmallow | Series B | $85M | Sep 2021 |
Top Co-Investors
Last updated: 8 March 2026